lifenews.com
2026-03-31
A strong majority of Americans of all political stripes support restoring regulations surrounding the abortion drug mifepristone, according to a new survey. A poll conducted by CRC Research found that more than two-thirds (67%) of Americans would support a decision by the Food and Drug Administration (FDA) to require an in-person physician's visit when prescribing and dispensing the abortion drug mifepristone. Over 70% of Republicans would support the move, along with a strong majority of both Independent voters (68%) and Democrats (63%). Only 27% of survey respondents said that they would oppose such a move from the FDA.
When the abortion drug was first approved by the FDA in 2000, it was regulated by a number of guidelines, including required physicians' visits before the drug could be prescribed, a requirement that the drug be dispensed and consumed in-person, and mandatory follow-up visits with a doctor. Presidents Barack Obama and Joe Biden weakened many of those safeguards in 2016 and in 2021, respectively, no longer mandating that the drug be prescribed or dispensed in-person and eliminating the previously-required physician's visits. At present, the abortion drug can be prescribed remotely and shipped across the nation through the mail. No follow-up appointments are required to address serious and life-threatening complications.